nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—cardial valve—systemic scleroderma	0.121	0.584	CbGeAlD
Cyclizine—SULT1E1—digestive system—systemic scleroderma	0.0288	0.139	CbGeAlD
Cyclizine—SULT1E1—lung—systemic scleroderma	0.024	0.116	CbGeAlD
Cyclizine—Blister—Captopril—systemic scleroderma	0.0141	0.0178	CcSEcCtD
Cyclizine—Jaundice cholestatic—Captopril—systemic scleroderma	0.0116	0.0146	CcSEcCtD
Cyclizine—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.0101	0.0127	CcSEcCtD
Cyclizine—Apnoea—Mycophenolic acid—systemic scleroderma	0.00944	0.0119	CcSEcCtD
Cyclizine—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.0091	0.0115	CcSEcCtD
Cyclizine—Bronchospasm—Pentoxifylline—systemic scleroderma	0.00829	0.0104	CcSEcCtD
Cyclizine—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.0082	0.0103	CcSEcCtD
Cyclizine—Dermatitis bullous—Captopril—systemic scleroderma	0.00773	0.00974	CcSEcCtD
Cyclizine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00751	0.00947	CcSEcCtD
Cyclizine—Apnoea—Mycophenolate mofetil—systemic scleroderma	0.00745	0.00939	CcSEcCtD
Cyclizine—Hepatic function abnormal—Azathioprine—systemic scleroderma	0.00738	0.0093	CcSEcCtD
Cyclizine—Speech disorder—Mycophenolate mofetil—systemic scleroderma	0.00734	0.00925	CcSEcCtD
Cyclizine—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00719	0.00906	CcSEcCtD
Cyclizine—Bronchospasm—Mometasone—systemic scleroderma	0.00715	0.00901	CcSEcCtD
Cyclizine—HRH1—connective tissue—systemic scleroderma	0.00713	0.0345	CbGeAlD
Cyclizine—Hepatobiliary disease—Pentoxifylline—systemic scleroderma	0.0071	0.00895	CcSEcCtD
Cyclizine—Hepatitis—Pentoxifylline—systemic scleroderma	0.00674	0.0085	CcSEcCtD
Cyclizine—HRH1—smooth muscle tissue—systemic scleroderma	0.00652	0.0316	CbGeAlD
Cyclizine—Bronchospasm—Captopril—systemic scleroderma	0.00628	0.00791	CcSEcCtD
Cyclizine—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00628	0.00791	CcSEcCtD
Cyclizine—Dermatitis bullous—Mycophenolic acid—systemic scleroderma	0.00608	0.00766	CcSEcCtD
Cyclizine—Hepatic function abnormal—Lisinopril—systemic scleroderma	0.00598	0.00754	CcSEcCtD
Cyclizine—Erythema—Pentoxifylline—systemic scleroderma	0.00587	0.0074	CcSEcCtD
Cyclizine—Tension—Pentoxifylline—systemic scleroderma	0.00576	0.00726	CcSEcCtD
Cyclizine—Nervousness—Pentoxifylline—systemic scleroderma	0.0057	0.00718	CcSEcCtD
Cyclizine—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00564	0.00711	CcSEcCtD
Cyclizine—Vision blurred—Pentoxifylline—systemic scleroderma	0.00553	0.00697	CcSEcCtD
Cyclizine—Urinary retention—Mycophenolic acid—systemic scleroderma	0.00552	0.00696	CcSEcCtD
Cyclizine—Tremor—Pentoxifylline—systemic scleroderma	0.0055	0.00693	CcSEcCtD
Cyclizine—Agitation—Pentoxifylline—systemic scleroderma	0.00539	0.0068	CcSEcCtD
Cyclizine—Angioedema—Pentoxifylline—systemic scleroderma	0.00536	0.00676	CcSEcCtD
Cyclizine—Agranulocytosis—Captopril—systemic scleroderma	0.00531	0.00669	CcSEcCtD
Cyclizine—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.00529	0.00667	CcSEcCtD
Cyclizine—CYP2C9—digestive system—systemic scleroderma	0.00522	0.0253	CbGeAlD
Cyclizine—HRH1—digestive system—systemic scleroderma	0.00515	0.0249	CbGeAlD
Cyclizine—Hepatitis—Captopril—systemic scleroderma	0.00511	0.00644	CcSEcCtD
Cyclizine—Convulsion—Pentoxifylline—systemic scleroderma	0.00508	0.00641	CcSEcCtD
Cyclizine—Hypertension—Pentoxifylline—systemic scleroderma	0.00507	0.00639	CcSEcCtD
Cyclizine—HRH1—tendon—systemic scleroderma	0.0049	0.0237	CbGeAlD
Cyclizine—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.00479	0.00604	CcSEcCtD
Cyclizine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00479	0.00604	CcSEcCtD
Cyclizine—Hepatobiliary disease—Azathioprine—systemic scleroderma	0.0047	0.00592	CcSEcCtD
Cyclizine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00467	0.00589	CcSEcCtD
Cyclizine—Skin disorder—Pentoxifylline—systemic scleroderma	0.00465	0.00586	CcSEcCtD
Cyclizine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00464	0.00584	CcSEcCtD
Cyclizine—Angioedema—Mometasone—systemic scleroderma	0.00463	0.00583	CcSEcCtD
Cyclizine—Hypotension—Pentoxifylline—systemic scleroderma	0.00448	0.00564	CcSEcCtD
Cyclizine—Bronchospasm—Lisinopril—systemic scleroderma	0.00445	0.0056	CcSEcCtD
Cyclizine—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.00444	0.00559	CcSEcCtD
Cyclizine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00438	0.00552	CcSEcCtD
Cyclizine—Tension—Captopril—systemic scleroderma	0.00436	0.0055	CcSEcCtD
Cyclizine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00436	0.00549	CcSEcCtD
Cyclizine—Insomnia—Pentoxifylline—systemic scleroderma	0.00433	0.00546	CcSEcCtD
Cyclizine—Nervousness—Captopril—systemic scleroderma	0.00432	0.00544	CcSEcCtD
Cyclizine—HRH1—lung—systemic scleroderma	0.0043	0.0208	CbGeAlD
Cyclizine—Somnolence—Pentoxifylline—systemic scleroderma	0.00426	0.00537	CcSEcCtD
Cyclizine—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.00423	0.00533	CcSEcCtD
Cyclizine—Apnoea—Methotrexate—systemic scleroderma	0.00422	0.00532	CcSEcCtD
Cyclizine—Hepatitis—Leflunomide—systemic scleroderma	0.00421	0.00531	CcSEcCtD
Cyclizine—Vision blurred—Captopril—systemic scleroderma	0.00419	0.00528	CcSEcCtD
Cyclizine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00418	0.00526	CcSEcCtD
Cyclizine—Speech disorder—Methotrexate—systemic scleroderma	0.00416	0.00524	CcSEcCtD
Cyclizine—Connective tissue disorder—Leflunomide—systemic scleroderma	0.00414	0.00522	CcSEcCtD
Cyclizine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00413	0.00521	CcSEcCtD
Cyclizine—Constipation—Pentoxifylline—systemic scleroderma	0.0041	0.00516	CcSEcCtD
Cyclizine—Angioedema—Captopril—systemic scleroderma	0.00406	0.00512	CcSEcCtD
Cyclizine—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00402	0.00506	CcSEcCtD
Cyclizine—Chills—Azathioprine—systemic scleroderma	0.004	0.00504	CcSEcCtD
Cyclizine—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00395	0.00498	CcSEcCtD
Cyclizine—Eye disorder—Leflunomide—systemic scleroderma	0.00394	0.00496	CcSEcCtD
Cyclizine—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.00381	0.0048	CcSEcCtD
Cyclizine—Urticaria—Pentoxifylline—systemic scleroderma	0.00381	0.0048	CcSEcCtD
Cyclizine—Chills—Leflunomide—systemic scleroderma	0.00378	0.00476	CcSEcCtD
Cyclizine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00376	0.00474	CcSEcCtD
Cyclizine—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00375	0.00473	CcSEcCtD
Cyclizine—Paraesthesia—Mometasone—systemic scleroderma	0.00371	0.00468	CcSEcCtD
Cyclizine—Mental disorder—Leflunomide—systemic scleroderma	0.00369	0.00465	CcSEcCtD
Cyclizine—Anaphylactic shock—Captopril—systemic scleroderma	0.00363	0.00458	CcSEcCtD
Cyclizine—Hepatitis—Lisinopril—systemic scleroderma	0.00362	0.00456	CcSEcCtD
Cyclizine—Chills—Mycophenolic acid—systemic scleroderma	0.0036	0.00454	CcSEcCtD
Cyclizine—Thrombophlebitis—Prednisone—systemic scleroderma	0.00359	0.00452	CcSEcCtD
Cyclizine—Tachycardia—Captopril—systemic scleroderma	0.00354	0.00447	CcSEcCtD
Cyclizine—Pain—Mometasone—systemic scleroderma	0.00353	0.00445	CcSEcCtD
Cyclizine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00353	0.00445	CcSEcCtD
Cyclizine—Muscle spasms—Leflunomide—systemic scleroderma	0.00352	0.00444	CcSEcCtD
Cyclizine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00352	0.00444	CcSEcCtD
Cyclizine—Vision blurred—Leflunomide—systemic scleroderma	0.00345	0.00435	CcSEcCtD
Cyclizine—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00345	0.00435	CcSEcCtD
Cyclizine—Asthenia—Pentoxifylline—systemic scleroderma	0.00344	0.00433	CcSEcCtD
Cyclizine—Tension—Mycophenolic acid—systemic scleroderma	0.00343	0.00433	CcSEcCtD
Cyclizine—Nervousness—Mycophenolic acid—systemic scleroderma	0.0034	0.00428	CcSEcCtD
Cyclizine—Hypotension—Captopril—systemic scleroderma	0.00339	0.00428	CcSEcCtD
Cyclizine—Pruritus—Pentoxifylline—systemic scleroderma	0.00339	0.00427	CcSEcCtD
Cyclizine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00336	0.00424	CcSEcCtD
Cyclizine—Angioedema—Leflunomide—systemic scleroderma	0.00335	0.00422	CcSEcCtD
Cyclizine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00334	0.00421	CcSEcCtD
Cyclizine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.0033	0.00415	CcSEcCtD
Cyclizine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.0033	0.00415	CcSEcCtD
Cyclizine—Insomnia—Captopril—systemic scleroderma	0.00328	0.00414	CcSEcCtD
Cyclizine—Tremor—Mycophenolic acid—systemic scleroderma	0.00328	0.00413	CcSEcCtD
Cyclizine—Paraesthesia—Captopril—systemic scleroderma	0.00326	0.00411	CcSEcCtD
Cyclizine—Chills—Lisinopril—systemic scleroderma	0.00325	0.00409	CcSEcCtD
Cyclizine—Somnolence—Captopril—systemic scleroderma	0.00323	0.00407	CcSEcCtD
Cyclizine—Agitation—Mycophenolic acid—systemic scleroderma	0.00321	0.00405	CcSEcCtD
Cyclizine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00317	0.004	CcSEcCtD
Cyclizine—Mental disorder—Lisinopril—systemic scleroderma	0.00317	0.004	CcSEcCtD
Cyclizine—Dizziness—Pentoxifylline—systemic scleroderma	0.00317	0.00399	CcSEcCtD
Cyclizine—Hypertension—Leflunomide—systemic scleroderma	0.00316	0.00399	CcSEcCtD
Cyclizine—Erythema—Lisinopril—systemic scleroderma	0.00315	0.00397	CcSEcCtD
Cyclizine—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00312	0.00393	CcSEcCtD
Cyclizine—Constipation—Captopril—systemic scleroderma	0.0031	0.00391	CcSEcCtD
Cyclizine—Tension—Lisinopril—systemic scleroderma	0.00309	0.0039	CcSEcCtD
Cyclizine—Skin disorder—Azathioprine—systemic scleroderma	0.00308	0.00388	CcSEcCtD
Cyclizine—Nervousness—Lisinopril—systemic scleroderma	0.00306	0.00386	CcSEcCtD
Cyclizine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00303	0.00382	CcSEcCtD
Cyclizine—Muscle spasms—Lisinopril—systemic scleroderma	0.00303	0.00382	CcSEcCtD
Cyclizine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00302	0.00381	CcSEcCtD
Cyclizine—Headache—Pentoxifylline—systemic scleroderma	0.003	0.00378	CcSEcCtD
Cyclizine—Thrombophlebitis—Methotrexate—systemic scleroderma	0.003	0.00378	CcSEcCtD
Cyclizine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00299	0.00377	CcSEcCtD
Cyclizine—Vision blurred—Lisinopril—systemic scleroderma	0.00297	0.00374	CcSEcCtD
Cyclizine—Asthenia—Mometasone—systemic scleroderma	0.00297	0.00374	CcSEcCtD
Cyclizine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00296	0.00373	CcSEcCtD
Cyclizine—Hypotension—Azathioprine—systemic scleroderma	0.00296	0.00373	CcSEcCtD
Cyclizine—Tremor—Lisinopril—systemic scleroderma	0.00295	0.00372	CcSEcCtD
Cyclizine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00293	0.0037	CcSEcCtD
Cyclizine—Pruritus—Mometasone—systemic scleroderma	0.00292	0.00369	CcSEcCtD
Cyclizine—Tachycardia—Leflunomide—systemic scleroderma	0.00292	0.00368	CcSEcCtD
Cyclizine—Skin disorder—Leflunomide—systemic scleroderma	0.00291	0.00366	CcSEcCtD
Cyclizine—Angioedema—Lisinopril—systemic scleroderma	0.00288	0.00363	CcSEcCtD
Cyclizine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00359	CcSEcCtD
Cyclizine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.0028	0.00353	CcSEcCtD
Cyclizine—Hypotension—Leflunomide—systemic scleroderma	0.0028	0.00352	CcSEcCtD
Cyclizine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00279	0.00351	CcSEcCtD
Cyclizine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00278	0.0035	CcSEcCtD
Cyclizine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00277	0.00349	CcSEcCtD
Cyclizine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00271	0.00341	CcSEcCtD
Cyclizine—Insomnia—Leflunomide—systemic scleroderma	0.00271	0.00341	CcSEcCtD
Cyclizine—Paraesthesia—Leflunomide—systemic scleroderma	0.00269	0.00339	CcSEcCtD
Cyclizine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00338	CcSEcCtD
Cyclizine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00267	0.00336	CcSEcCtD
Cyclizine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00334	CcSEcCtD
Cyclizine—Asthenia—Captopril—systemic scleroderma	0.0026	0.00328	CcSEcCtD
Cyclizine—Headache—Mometasone—systemic scleroderma	0.00259	0.00326	CcSEcCtD
Cyclizine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00259	0.00326	CcSEcCtD
Cyclizine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00258	0.00325	CcSEcCtD
Cyclizine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00257	0.00324	CcSEcCtD
Cyclizine—Pruritus—Captopril—systemic scleroderma	0.00257	0.00324	CcSEcCtD
Cyclizine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00256	0.00323	CcSEcCtD
Cyclizine—Pain—Leflunomide—systemic scleroderma	0.00256	0.00322	CcSEcCtD
Cyclizine—Constipation—Leflunomide—systemic scleroderma	0.00256	0.00322	CcSEcCtD
Cyclizine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00254	0.0032	CcSEcCtD
Cyclizine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00254	0.0032	CcSEcCtD
Cyclizine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00318	CcSEcCtD
Cyclizine—Tachycardia—Lisinopril—systemic scleroderma	0.00251	0.00316	CcSEcCtD
Cyclizine—Skin disorder—Lisinopril—systemic scleroderma	0.0025	0.00315	CcSEcCtD
Cyclizine—Pain—Mycophenolic acid—systemic scleroderma	0.00244	0.00308	CcSEcCtD
Cyclizine—Constipation—Mycophenolic acid—systemic scleroderma	0.00244	0.00308	CcSEcCtD
Cyclizine—Hypotension—Lisinopril—systemic scleroderma	0.0024	0.00303	CcSEcCtD
Cyclizine—Dizziness—Captopril—systemic scleroderma	0.0024	0.00303	CcSEcCtD
Cyclizine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00301	CcSEcCtD
Cyclizine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00238	0.003	CcSEcCtD
Cyclizine—Urticaria—Leflunomide—systemic scleroderma	0.00238	0.003	CcSEcCtD
Cyclizine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00233	0.00294	CcSEcCtD
Cyclizine—Insomnia—Lisinopril—systemic scleroderma	0.00233	0.00293	CcSEcCtD
Cyclizine—Paraesthesia—Lisinopril—systemic scleroderma	0.00231	0.00291	CcSEcCtD
Cyclizine—Somnolence—Lisinopril—systemic scleroderma	0.00229	0.00288	CcSEcCtD
Cyclizine—Headache—Captopril—systemic scleroderma	0.00227	0.00287	CcSEcCtD
Cyclizine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00284	CcSEcCtD
Cyclizine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00278	CcSEcCtD
Cyclizine—Hypersensitivity—Leflunomide—systemic scleroderma	0.0022	0.00278	CcSEcCtD
Cyclizine—Constipation—Lisinopril—systemic scleroderma	0.0022	0.00277	CcSEcCtD
Cyclizine—Pain—Lisinopril—systemic scleroderma	0.0022	0.00277	CcSEcCtD
Cyclizine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00277	CcSEcCtD
Cyclizine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00219	0.00276	CcSEcCtD
Cyclizine—Asthenia—Leflunomide—systemic scleroderma	0.00215	0.00271	CcSEcCtD
Cyclizine—Pruritus—Leflunomide—systemic scleroderma	0.00212	0.00267	CcSEcCtD
Cyclizine—Connective tissue disorder—Prednisone—systemic scleroderma	0.00211	0.00266	CcSEcCtD
Cyclizine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.0021	0.00265	CcSEcCtD
Cyclizine—Dizziness—Azathioprine—systemic scleroderma	0.00209	0.00264	CcSEcCtD
Cyclizine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00205	0.00258	CcSEcCtD
Cyclizine—Urticaria—Lisinopril—systemic scleroderma	0.00204	0.00257	CcSEcCtD
Cyclizine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00257	CcSEcCtD
Cyclizine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00255	CcSEcCtD
Cyclizine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00202	0.00255	CcSEcCtD
Cyclizine—Eye disorder—Prednisone—systemic scleroderma	0.00201	0.00253	CcSEcCtD
Cyclizine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.002	0.00252	CcSEcCtD
Cyclizine—Drowsiness—Methotrexate—systemic scleroderma	0.002	0.00252	CcSEcCtD
Cyclizine—Headache—Azathioprine—systemic scleroderma	0.00198	0.0025	CcSEcCtD
Cyclizine—Dizziness—Leflunomide—systemic scleroderma	0.00198	0.00249	CcSEcCtD
Cyclizine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00243	CcSEcCtD
Cyclizine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00243	CcSEcCtD
Cyclizine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00189	0.00239	CcSEcCtD
Cyclizine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00189	0.00238	CcSEcCtD
Cyclizine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00189	0.00238	CcSEcCtD
Cyclizine—Mental disorder—Prednisone—systemic scleroderma	0.00188	0.00237	CcSEcCtD
Cyclizine—Headache—Leflunomide—systemic scleroderma	0.00187	0.00236	CcSEcCtD
Cyclizine—Erythema—Prednisone—systemic scleroderma	0.00187	0.00236	CcSEcCtD
Cyclizine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00187	0.00235	CcSEcCtD
Cyclizine—Asthenia—Lisinopril—systemic scleroderma	0.00184	0.00232	CcSEcCtD
Cyclizine—Pruritus—Lisinopril—systemic scleroderma	0.00182	0.00229	CcSEcCtD
Cyclizine—Hepatitis—Methotrexate—systemic scleroderma	0.0018	0.00226	CcSEcCtD
Cyclizine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00226	CcSEcCtD
Cyclizine—Headache—Mycophenolic acid—systemic scleroderma	0.00179	0.00225	CcSEcCtD
Cyclizine—Vision blurred—Prednisone—systemic scleroderma	0.00176	0.00222	CcSEcCtD
Cyclizine—Agitation—Prednisone—systemic scleroderma	0.00172	0.00217	CcSEcCtD
Cyclizine—Angioedema—Prednisone—systemic scleroderma	0.00171	0.00215	CcSEcCtD
Cyclizine—Dizziness—Lisinopril—systemic scleroderma	0.0017	0.00214	CcSEcCtD
Cyclizine—Eye disorder—Methotrexate—systemic scleroderma	0.00168	0.00212	CcSEcCtD
Cyclizine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00209	CcSEcCtD
Cyclizine—Convulsion—Prednisone—systemic scleroderma	0.00162	0.00204	CcSEcCtD
Cyclizine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00204	CcSEcCtD
Cyclizine—Hypertension—Prednisone—systemic scleroderma	0.00162	0.00204	CcSEcCtD
Cyclizine—Chills—Methotrexate—systemic scleroderma	0.00161	0.00203	CcSEcCtD
Cyclizine—Headache—Lisinopril—systemic scleroderma	0.00161	0.00203	CcSEcCtD
Cyclizine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00201	CcSEcCtD
Cyclizine—Mental disorder—Methotrexate—systemic scleroderma	0.00157	0.00198	CcSEcCtD
Cyclizine—Erythema—Methotrexate—systemic scleroderma	0.00156	0.00197	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00153	0.00192	CcSEcCtD
Cyclizine—Nervous system disorder—Prednisone—systemic scleroderma	0.0015	0.00189	CcSEcCtD
Cyclizine—Tachycardia—Prednisone—systemic scleroderma	0.00149	0.00188	CcSEcCtD
Cyclizine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00188	CcSEcCtD
Cyclizine—Skin disorder—Prednisone—systemic scleroderma	0.00148	0.00187	CcSEcCtD
Cyclizine—Vision blurred—Methotrexate—systemic scleroderma	0.00147	0.00186	CcSEcCtD
Cyclizine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00178	CcSEcCtD
Cyclizine—Insomnia—Prednisone—systemic scleroderma	0.00138	0.00174	CcSEcCtD
Cyclizine—Paraesthesia—Prednisone—systemic scleroderma	0.00137	0.00173	CcSEcCtD
Cyclizine—Convulsion—Methotrexate—systemic scleroderma	0.00135	0.00171	CcSEcCtD
Cyclizine—Constipation—Prednisone—systemic scleroderma	0.00131	0.00165	CcSEcCtD
Cyclizine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00128	0.00161	CcSEcCtD
Cyclizine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00125	0.00158	CcSEcCtD
Cyclizine—Skin disorder—Methotrexate—systemic scleroderma	0.00124	0.00156	CcSEcCtD
Cyclizine—Urticaria—Prednisone—systemic scleroderma	0.00121	0.00153	CcSEcCtD
Cyclizine—Hypotension—Methotrexate—systemic scleroderma	0.00119	0.0015	CcSEcCtD
Cyclizine—Insomnia—Methotrexate—systemic scleroderma	0.00115	0.00145	CcSEcCtD
Cyclizine—Paraesthesia—Methotrexate—systemic scleroderma	0.00115	0.00144	CcSEcCtD
Cyclizine—Somnolence—Methotrexate—systemic scleroderma	0.00113	0.00143	CcSEcCtD
Cyclizine—Hypersensitivity—Prednisone—systemic scleroderma	0.00112	0.00142	CcSEcCtD
Cyclizine—Asthenia—Prednisone—systemic scleroderma	0.0011	0.00138	CcSEcCtD
Cyclizine—Pain—Methotrexate—systemic scleroderma	0.00109	0.00138	CcSEcCtD
Cyclizine—Pruritus—Prednisone—systemic scleroderma	0.00108	0.00136	CcSEcCtD
Cyclizine—Urticaria—Methotrexate—systemic scleroderma	0.00101	0.00128	CcSEcCtD
Cyclizine—Dizziness—Prednisone—systemic scleroderma	0.00101	0.00127	CcSEcCtD
Cyclizine—Headache—Prednisone—systemic scleroderma	0.000956	0.00121	CcSEcCtD
Cyclizine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00094	0.00118	CcSEcCtD
Cyclizine—Asthenia—Methotrexate—systemic scleroderma	0.000915	0.00115	CcSEcCtD
Cyclizine—Pruritus—Methotrexate—systemic scleroderma	0.000903	0.00114	CcSEcCtD
Cyclizine—Dizziness—Methotrexate—systemic scleroderma	0.000844	0.00106	CcSEcCtD
Cyclizine—Headache—Methotrexate—systemic scleroderma	0.000799	0.00101	CcSEcCtD
